Literature DB >> 12513653

Ocular safety: a silent (in vitro) success story.

Rodger D Curren1, John W Harbell.   

Abstract

Ocular irritation testing has been one of the animal test methods most criticised by animal welfare advocates. Additional criticism has arisen from within the scientific community, based on the variability of the animal test results and the questionable relevance of the extremely high dose levels employed. As a result, the Draize eye irritation test has been one of the main targets for in vitro replacement. Despite extensive efforts, however, there is still no in vitro method that is fully validated as a regulatory replacement. In spite of this, many individual companies are using diverse in vitro ocular irritation tests to gain important safety and efficacy information about their products and raw materials, eliminating the need for animal testing in the process. This is done in a safe fashion by applying intelligent testing paradigms. ECVAM has played a major role in this success, through its many programmes that have emphasised the importance of understanding the true toxicological need, and then using in vitro tests to provide that information. Thus, even in the absence of a successfully validated regulatory assay, the desired result of reducing animal testing is being met.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12513653     DOI: 10.1177/026119290203002S10

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  8 in total

Review 1.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

Review 2.  Corneal tissue engineering: recent advances and future perspectives.

Authors:  Chiara E Ghezzi; Jelena Rnjak-Kovacina; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2015-02-10       Impact factor: 6.389

3.  In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).

Authors:  Christophe Baudouin; Alexandre Denoyer; Nicolas Desbenoit; Gregory Hamm; Alice Grise
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

4.  In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells.

Authors:  Ana Guzman-Aranguez; Patricia Calvo; Inés Ropero; Jesús Pintor
Journal:  J Ocul Pharmacol Ther       Date:  2014-08-06       Impact factor: 2.671

Review 5.  In Vitro Cell Models for Ophthalmic Drug Development Applications.

Authors:  Sara Shafaie; Victoria Hutter; Michael T Cook; Marc B Brown; David Y S Chau
Journal:  Biores Open Access       Date:  2016-04-01

6.  Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay.

Authors:  Susanne N Kolle; Ursula G Sauer; Maria C Rey Moreno; Wera Teubner; Wendel Wohlleben; Robert Landsiedel
Journal:  Part Fibre Toxicol       Date:  2016-04-15       Impact factor: 9.400

Review 7.  The Different Facades of Retinal and Choroidal Endothelial Cells in Response to Hypoxia.

Authors:  Effat Alizadeh; Parviz Mammadzada; Helder André
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

8.  Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model.

Authors:  Yulia Kaluzhny; Helena Kandárová; Laurence d'Argembeau-Thornton; Paul Kearney; Mitchell Klausner
Journal:  J Vis Exp       Date:  2015-08-23       Impact factor: 1.355

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.